A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research shows that the therapy activates the immune system’s T cells, which then attack the abnormal skin cells.
from Top Health News – ScienceDaily http://ift.tt/2gGMRgN
from Tumblr http://ift.tt/2gym1qt
No comments:
Post a Comment